首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters.
【2h】

Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters.

机译:保守和人类特异性启动子对人类甲状旁腺激素(PTH)/ PTH相关肽受体基因表达的发育上调。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor (PTHR) functions in skeletal development and mediates an array of other physiological responses modulated by PTH and PTHrP. PTHR gene transcription in mouse is controlled by two promoters: P1, which is highly and selectively active in kidney; and P2, which functions in a variety of tissues. P1 and P2 are conserved in human tissue; however, P1 activity in kidney is weak. We have now identified a third human promoter, P3, which is widely expressed and accounts for approximately 80% of renal PTHR transcripts in the adult. No P3 activity was detected in mouse kidney, indicating that renal PTHR gene expression is controlled by different signals in human and mouse. During development, only P2 is active at midgestation in many human tissues, including calvaria and long bone. This strongly suggests that factors regulating well conserved P2 control PTHR gene expression during skeletal development. Our results indicate that human PTHR gene transcription is upregulated late in development with the induction of both P1 and P3 promoter activities. In addition, P2-specific transcripts are differentially spliced in a number of human cell lines and adult tissues, but not in fetal tissues, giving rise to a shorter and less structured 5' UTR. Thus, our studies show that both human PTHR gene transcription and mRNA splicing are developmentally regulated. Moreover, our data indicate that renal and nonrenal PTHR gene expression are tightly coordinated in humans.
机译:甲状旁腺激素(PTH)/ PTH相关肽(PTHrP)受体(PTHR)在骨骼发育中起作用,并介导一系列由PTH和PTHrP调节的其他生理反应。小鼠中的PTHR基因转录受两个启动子控制:P1在肾脏中具有高度选择性的活性; P2在各种组织中起作用。 P1和P2在人体组织中保守;但是,肾脏中的P1活性较弱。现在,我们已经确定了第三个人类启动子P3,该启动子被广泛表达,约占成年人肾脏PTHR转录物的80%。在小鼠肾脏中未检测到P3活性,表明肾脏PTHR基因表达受人和小鼠中不同信号的控制。在发育过程中,许多人组织(包括颅骨和长骨)在妊娠中期只有P2活跃。这有力地表明,调节骨骼保守的P2的因子可控制PTHR基因的表达。我们的结果表明,人PTHR基因转录在发育后期随着P1和P3启动子活性的诱导而上调。此外,P2特异性转录本在许多人类细胞系和成年组织中有差异剪接,但在胎儿组织中无差异剪接,从而产生了较短且结构较少的5'UTR。因此,我们的研究表明人类PTHR基因转录和mRNA剪接均受到发育调控。此外,我们的数据表明,肾脏和非肾脏PTHR基因的表达在人类中是紧密协调的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号